-
Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacy
Veldkamp, S. R., Reugebrink, M., Evers, S. W., Moreau, T. R. J., Bondet, V., Armbrust, W., van den Berg, J. M., Hissink Muller, P. C. E., Kamphuis, S., Schatorjé, E., Delemarre, E. M., van der Kooi, A. J., Bader-Meunier, B., Duffy, D., Rodero, M. P., Raaphorst, J., van Royen-Kerkhof, A., Jansen, M. H. A. & van Wijk, F., 1 Sept 2025, In: Nature Clinical Practice Rheumatology. 64, 9, p. 5132-5141 10 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
